EFFECT PROCESSING VARIABLES ON THE CHARACTERISTICS OF ITRACONAZOLE HOLLOW MICROSPHERES

Hollow Microspheres of Itraconazole

Authors

  • SURBHI ROHILLA Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India
  • D. C. BHATT Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India
  • SHAVETA AHALWAT Department of Pharmaceutical Sciences, Guru Jambheshwar University of Science and Technology, Hisar, Haryana 125001, India

DOI:

https://doi.org/10.22159/ijap.2019v11i6.35098

Keywords:

Floating hollow microspheres, Itraconazole, Stomach specific delivery

Abstract

Objective: The purpose of the study was to develop the multiple unit non-effervescent gastroretentive floating hollow microspheres to enhance the bioavailability of the drug by varying the concentration of low-density polymer and release modifier to retaining the formulation at its absorption site. Design of experiment approach applied to get the best possible formulation with minimum assets and experimentation.

Methods: The hollow microspheres were prepared by emulsion solvent diffusion-evaporation technique using ethylcellulose as low-density polymer and Eudragit E100 as release modifier. The central composite design was used for the optimization of independent variables and was evaluated for particle size, entrapment efficiency, in vitro floating ability and drug release characteristics.

Results: The physicochemical analysis was done to confirm any interaction between drug and excipients. The Scanning Electron Microscopy (SEM) showed a smooth, spherical surface with an inner hollow cavity. The stability study proves that the hollow microspheres were more stable under different storage conditions with no significant changes in formulation. The drug release mechanism of the optimized batch can be explained by Korsmeyer Peppas model.

Conclusion: Based on the results, the hollow microspheres with a release modifying polymer offers a superior approach to retain the formulation in the stomach.

Downloads

Download data is not yet available.

References

Hong JY, Kim JK, Song YK, Park JS, Kim CK. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Controlled Release 2006;110:332-8.

Prentice AG, Glasmacher A. Making sense of itraconazole pharmacokinetics. J Antimicrob Chemother 2005;56(Suppl 1):i17-22.

Domínguez Gil Hurle A, Sanchez Navarro A, Garcia Sanchez MJ. Therapeutic drug monitoring of itraconazole and the relevance of pharmacokinetic interactions. Clin Microbiol Infect 2006;12:97-106.

Darwazeh AM, Darwazeh TA. What makes oral candidiasis recurrent infection? a clinical view. Mycologia 2014. http://dx.doi.org/10.1155/2014/758394

Kim JY, Rhee YS, Park CW, Ha JM, Park ES. Preparation and evaluation of dual-mode floating gastroretentive tablets containing itraconazole. Drug Delivery 2014;21:519-29.

Madgulkar A, Kadam S, Pokharkar V. Studies on formulation development of mucoadhesive sustained-release itraconazole tablet using response surface methodology. AAPS PharmSciTech 2008;9:998.

Thakkar HP, Khunt A, Dhande RD, Patel AA. Formulation and evaluation of Itraconazole nanoemulsion for enhanced oral bioavailability. J Microencapsulation 2015;32:559-69.

Zhong Y, Jing G, Tian B, Huang H, Zhang Y, Gou J, et al. Supersaturation induced by Itraconazole/Soluplus® micelles provided high GI absorption in vivo. Asian J Pharm 2016;11:255-64.

Yi Y, Yoon HJ, Kim BO, Shim M, Kim SO, Hwang SJ, et al. A mixed polymeric micellar formulation of itraconazole: characteristics, toxicity, and pharmacokinetics. J Controlled Release 2007;117:59-67.

Türkmen B, Gökbulut E, Ozdemi N. A new approach to enhance bioavailability: dosage forms with extended residence time in the stomach. FABAD J Pharm Sci 2017;42:9.

Rao MR, Borate SG, Thanki KC, Ranpise AA, Parikh GN. Development and in vitro evaluation of floating rosiglitazone maleate microspheres. Drug Dev Ind Pharm 2009;35:834-42.

Kohli S, Sharma M, Pal A. Ethylcellulose floating microspheres of antidiabetic agent: in vitro and in vivo evaluation. Int J Appl Pharm 2016;9:44-9.

Panwar MM. Factorial design approach for optimization of floating microspheres of diltiazem hydrochloride. Asian J Pharm 2015;9:206-12.

Murtaza G. Ethylcellulose microparticles: a review. Acta Pol Pharm 2012;69:11-22.

Mastiholimath VS, Dandagi PM, Gadad AP, Mathews R, Kulkarni AR. In vitro and in vivo evaluation of ranitidine hydrochloride ethyl cellulose floating microparticles. J Microencapsulation 2008;25:307-14.

Vaghani S, Vasanti S, Chaturvedi K, Satish CS, Jivani NP. Stomach-specific drug delivery of 5-fluorouracil using ethylcellulose floating microspheres. Pharm Dev Technol 2010;15:154-61.

Assas N, Elbahri Z, Baitiche M, Djerboua F. Effects of some process parameters on the niflumic acid controlled release polymeric microspheres: optimization using designs of experiments. Asia Pacific J Chem Eng 2019:e2283. https://doi.org/10.1002/apj.2283

Emeje MO, Kunle OO, Ofoefule SI. Compaction characteristics of ethylcellulose in the presence of some channeling agents. AAPS PharmSciTech 2006;7:E18-21.

Farooq U, Khan S, Nawaz S, Ranjha NM, Haider MS, Khan MM, et al. Enhanced gastric retention and drug release via development of novel floating microspheres based on Eudragit E100 and polycaprolactone: synthesis and in vitro evaluation. Des Monomers Polym 2017;20:419-33.

Kawashima Y, Niwa T, Takeuchi H, Hino T, Itoh Y. Hollow microspheres for use as a floating controlled drug delivery system in the stomach. J Pharm Sci 1992;81:135-40.

El-Kamel AH, Sokar MS, Al Gamal SS, Naggar VF. Preparation and evaluation of ketoprofen floating oral delivery system1. Int J Pharm 2001;220:13-21.

Junyaprasert VB, Pornsuwannapha S. Floating properties and release characteristics of hollow microspheres of acyclovir. Drug Delivery 2008;15:331-41.

Kawashima Y, Niwa T, Takeuchi H, Hino T, Ito Y. Preparation of multiple unit hollow microspheres (microballoons) with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behavior (in vivo). J Controlled Release 1991;16:279-89.

Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. Physicochemical properties to determine the buoyancy of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 2003;55:297-304.

Gaur PK, Mishra S, Bajpai M. Formulation and evaluation of controlled-release of telmisartan microspheres: in vitro/in vivo study. J Food Drug Anal 2014;22:542-8.

El Nashar NF, Donia AA, Mady OY, El Maghraby GM. Formulation of clarithromycin floating microspheres for eradication of Helicobacter pylori. J Drug Delivery Sci Technol 2017;41:213-21.

Najmuddin M, Ahmed A, Shelar S, Patel V, Khan T. Floating microspheres of ketoprofen: formulation and evaluation. Int J Pharm Pharm Sci 2010;2:83-7.

Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm 2010;67:217-3.

Costa P, Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123-33.

Matthews BR. Regulatory aspects of stability testing in Europe. Drug Dev Ind Pharm 1999;25:831-56.

Pandit V, Pai RS, Yadav V, Devi K, Surekha BB, Inamdar MN, Suresh S. Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride. Drug Dev Ind Pharm 2013;39:117-27.

Sharma M, Kohli S, Pal A. Stability of floating microspheres at normal and accelerated conditions. Int J Pharm Pharm Sci 2016;8:452-4.

Mohamed AI, Abd-Motagaly AM, Ahmed OA, Amin S, Mohamed Ali AI. Investigation of drug-polymer compatibility using chemometric-assisted UV-spectrophotometry. Pharmaceutics 2017;9:7.

Dinte EL, Bodoki E, Leucuta S, Iuga CA. Compatibility studies between drugs and excipients in the preformulation phase of buccal mucoadhesive systems. Farmacia 2013;61:703-12.

Sato Y, Kawashima Y, Takeuchi H, Yamamoto H. In vitro evaluation of floating and drug-releasing behaviors of hollow microspheres (microballoons) prepared by the emulsion solvent diffusion method. Eur J Pharm Biopharm 2004;57:235-43.

Pachuau L, Mazumder B. A study on the effects of different surfactants on Ethylcellulose microspheres. Int J Pharm Tech Res 2009;1:966-71.

Published

07-11-2019

How to Cite

ROHILLA, S., BHATT, D. C., & AHALWAT, S. (2019). EFFECT PROCESSING VARIABLES ON THE CHARACTERISTICS OF ITRACONAZOLE HOLLOW MICROSPHERES: Hollow Microspheres of Itraconazole. International Journal of Applied Pharmaceutics, 11(6), 108–115. https://doi.org/10.22159/ijap.2019v11i6.35098

Issue

Section

Original Article(s)